ASSOCIATION OF RISK FACTORS OF CEREBRAL PALSY – A MATCHED CASE CONTROL STUDY

2020 ◽  
Vol 7 (2) ◽  
Author(s):  
C. HEMACHITHRA ◽  
N. MEENA ◽  
R. RAMANATHAN ◽  
A. J. W. FELIX
2020 ◽  
Vol 20 (3) ◽  
pp. 321-328
Author(s):  
Junichi Kushioka ◽  
Shota Takenaka ◽  
Takahiro Makino ◽  
Yusuke Sakai ◽  
Masafumi Kashii ◽  
...  

2021 ◽  
Vol 223 ◽  
pp. 140-148
Author(s):  
Ken-Kuo Lin ◽  
Jiahn-Shing Lee ◽  
Chiun-Ho Hou ◽  
Wei-Min Chen ◽  
Ching-Hsi Hsiao ◽  
...  

2014 ◽  
Vol 6 (2) ◽  
pp. 329-338
Author(s):  
N. Quraishi ◽  
U. Bhosale ◽  
R. Yegnanarayan ◽  
D. Devasthale

This study was conducted to assess and compare the cardiovascular risk and to explore the demography of CV risk of nonselective cyclooxygenase inhibitors (COX-Is) and selective COX-2-Is in arthritic patients. In this comparative matched case control study adult arthritic patients of either sex taking COX-Is for >1 yr; were included. Arthritic age and sex matched individuals with no history of COX-Is treatment were the controls. Patients those with history of any other disease (e.g. diabetes, hypertension, stroke, IHD etc.) were excluded. Patients were grouped into Control, nonselective COX-I and selective COX-2-I groups. The CV risk factors like blood pressure, blood sugar level(BSL), lipid profile, BMI(body mass index) etc. were assessed and compared; demography of CV risk factors i.e. age, sex, smoking, alcohol, heredity was also studied. Qualitative data was analyzed using Chi-square and quantitative data was analyzed by student’s‘t’-test. Study clearly revealed that all NSAIDs exhibit significant CV risk when taken over a period of time as in arthritis. However selective COX 2-Is found to exhibit more CV risk in this regard. Odds ratio (OR) for CV risk=10.3(95% CI: 1.45, 3.31) and OR for CV risk=5.2(95%CI: 1.05, 2.57) for nonselective COX-Is. BMI, BSL and lipid profile; the potential CV risk factors, showed significant impairment in selective COX 2-Is group; P<0.05, P<0.05 and P<0.01 (HDL), P<0.001 (cholesterol), respectively compared to controls and P<0.05 compared to nonselective COX-Is. This study portrays the potential CV risk of selective COX 2-Is and confirms and re-evaluate the results of earlier studies in this regard.  Keywords: Anti-arthritic agents; BMI; COX-Is; CV risk; Lipid profile.  © 2014 JSR Publications. ISSN: 2070-0237 (Print); 2070-0245 (Online). All rights reserved.  doi: http://dx.doi.org/10.3329/jsr.v6i2.17039 J. Sci. Res. 6 (2), 328-338 (2014)  


2011 ◽  
Vol 44 (2) ◽  
pp. 125-130 ◽  
Author(s):  
Hong-Jyun Chang ◽  
Po-Chang Hsu ◽  
Chien-Chang Yang ◽  
An-Jing Kuo ◽  
Ju-Hsin Chia ◽  
...  

Injury ◽  
2017 ◽  
Vol 48 (10) ◽  
pp. 2342-2347 ◽  
Author(s):  
Peter C. Noback ◽  
Eugene S. Jang ◽  
Derly O. Cuellar ◽  
Mani Seetharaman ◽  
Emiliano Malagoli ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document